There are 3158 resources available
Q&A and discussion
Session: Promises and pitfalls in earlier stage NSCLC
Resources:
Webcast
Discussion
Session: Controversies in the management and follow up of small localised neuroendocrine tumours
Resources:
Webcast
How to select patients? Models to predict response
Presenter: Ingeborg Tinhofer-Keilholz
Session: New therapeutic approaches in concomitant chemoradiotherapy
Resources:
Slides
Webcast
Q&A and discussion
Session: New therapeutic approaches in concomitant chemoradiotherapy
Resources:
Webcast
LBA8 - Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients with PD-(L)1 inhibitors resistance (PIONeeR): A phase Ib/IIa clinical trial targeting identified resistance pathways
Presenter: Pascale Tomasini
Session: Presidential Symposium III: Eyes to the future
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA8: Discovering mechanisms of resistance to standard therapy
Presenter: Biagio Ricciuti
Session: Presidential Symposium III: Eyes to the future
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Jean Bourhis
Session: New therapeutic approaches in concomitant chemoradiotherapy
Resources:
Webcast
604O - Phase I dose escalation and initial dose expansion results of AMG 193: A MTA-cooperative PRMT5 inhibitor, in patients (pts) with MTAP-deleted solid tumors
Presenter: Adrian Sacher
Session: Presidential Symposium III: Eyes to the future
Resources:
Abstract
Slides
Webcast
Invited Discussant 604O: Epigenetic modulation of the tumour and its microenvironment
Presenter: Cigall Kadoch
Session: Presidential Symposium III: Eyes to the future
Resources:
Slides
Webcast
Q&A and discussion
Session: Presidential Symposium III: Eyes to the future
Resources:
Webcast